Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-08-05Phase I Trial Of Intravenous Bispecific Antibody (4G7XH22) In Patients With Refractory Or Relapsed Non-Hodgkin's Lymphoma Or Chronic Lymphocytic Leukemia (CLL)
-
CLINICAL_TRIALS study record update · 2013-08-02A Phase I Study of Cytosine Arabinoside, Idarubicin, and Amifostine as Induction Therapy for Patients With Newly Diagnosed Acute Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2013-08-02A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) With or Without Rituximab in Previously Treated Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2013-08-02Phase II Trial Comparing Combination Treatment With Fludarabine and Alemtuzumab to Fludarabine and Rituximab in Patients With B-Cell Chronic Lymphocytic Leukemia Requiring Treatment After First Line Therapy
-
CLINICAL_TRIALS study record update · 2013-08-02PROSPECTIVE CONTROLLED STUDY FOR THE OPTIMIZATION OF THERAPY IN CHRONIC MYELOID LEUKEMIA (CML): MULTICENTRIC STUDY FOR THE EVALUATION OF INTERFERON ALPHA VS ALLOGENIC BM TRANSPLANTATION WITH CHEMOTHERAPY IN CML
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-07-30Phase II Pilot Trial to Evaluate the Efficacy of a Combined Therapy Approach for Young CLL Patients With Advanced and Progressive Disease Stratified According to the Biological Prognostic Features
-
CLINICAL_TRIALS study record update · 2013-07-30Phase II Trial of Everolimus (RAD001) in Relapsed/Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2013-07-26A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES
-
CLINICAL_TRIALS study record update · 2013-07-25Randomized Phase-III Trial Comparing Fludarabine and Cyclophosphamide Plus Rituximab (FCR) to FC and MabCampath (FCCam) for Previously Untreated Fit Patients With Chronic Lymphocytic Leukemia (CLL)
-
CLINICAL_TRIALS study record update · 2013-07-24Hematopoietic Stem Cell Transplantation Using Bone Marrow Or Peripheral Blood Stem Cells From Matched, Unrelated, Volunteer Donors
-
CLINICAL_TRIALS study record update · 2013-07-24Efficacy and Safety of Direct Intrabone Transplantation of Peripheral Blood Haematopoietic Stem Cells Form HLA-matched Sibling Donors in Patients With Myeloid and Lymphoid Malignancies.
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Study of Triapine and Cytarabine in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Study Of VNP40101M And Cytarabine For Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I/II Study of Cloretazine in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia or Richter's Syndrome
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase II Study of VNP40101M For Patients With Acute Myelogenous Leukemia Or High-Risk Myelodysplasia
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Study Of Cloretazine™ (VNP40101M) And Temozolomide In Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-07-18A Multicenter Study to Assess the Efficacy of 506U78 in Patients With Chronic Lymphocytic Leukemia Who Are Refractory to Fludarabine and Alkylator Therapy
-
CLINICAL_TRIALS study record update · 2013-07-18A Phase I Trial Of VNP40101M, A Novel Alkylating Agent, For Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-07-15Feasibility of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation Followed by Donor Lymphocyte Infusions for Children at High Risk for Complications With Conventional Transplantation
-
CLINICAL_TRIALS study record update · 2013-07-11Phase II Study of Epirubicin and Rituximab in Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma and CLL
-
CLINICAL_TRIALS study record update · 2013-07-11Infusion of Genetically Modified T Cells: A Pilot Study of Tracking and Toxicity
-
CLINICAL_TRIALS study record update · 2013-07-10Genomic Analysis of Adolescent and Young Adult Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2013-07-10HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOR CHILDREN WITH RELAPSED ACUTE LYMPHOCYTIC LEUKEMIA
-
CLINICAL_TRIALS study record update · 2013-07-10The Genetics of "Non-Response" in Adult AML
-
CLINICAL_TRIALS study record update · 2013-07-10A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered CNF1010 )17-(Allylamino)-17-Demethoxygeldanamycin [17-AAG]) in Patients With Gleevec-Resistent Chronic Myelogenous Leukemia